|
Volumn 8, Issue 10, 2013, Pages e77745-
|
The vitamin D receptor agonist BXL-01-0029 as a potential new pharmacological tool for the treatment of inflammatory myopathies
a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CALCITRIOL RECEPTOR;
CCL2 PROTEIN, HUMAN;
CXCL10 PROTEIN, HUMAN;
GAMMA INTERFERON;
GAMMA INTERFERON INDUCIBLE PROTEIN 10;
IMMUNOSUPPRESSIVE AGENT;
INTERLEUKIN DERIVATIVE;
MACROPHAGE INFLAMMATORY PROTEIN 1BETA;
MONOCYTE CHEMOTACTIC PROTEIN 1;
TUMOR NECROSIS FACTOR ALPHA;
ADULT;
AGED;
AGONISTS;
CELL CULTURE;
DRUG EFFECTS;
FEMALE;
HUMAN;
MALE;
METABOLISM;
MIDDLE AGED;
MUSCLE CELL;
MYOSITIS;
SIGNAL TRANSDUCTION;
SKELETAL MUSCLE;
VERY ELDERLY;
ADULT;
AGED;
AGED, 80 AND OVER;
CELLS, CULTURED;
CHEMOKINE CCL2;
CHEMOKINE CCL4;
CHEMOKINE CXCL10;
FEMALE;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
INTERFERON-GAMMA;
INTERLEUKINS;
MALE;
MIDDLE AGED;
MUSCLE CELLS;
MUSCLE, SKELETAL;
MYOSITIS;
RECEPTORS, CALCITRIOL;
SIGNAL TRANSDUCTION;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 84901486766
PISSN: None
EISSN: 19326203
Source Type: Journal
DOI: 10.1371/journal.pone.0077745 Document Type: Article |
Times cited : (25)
|
References (0)
|